Feature

HHS to allow insurers’ workaround on 2019 prices


 


“It’s not an easy question,” Mr. Azar said.

The fact that the federal government ended up effectively making the payments aggravated many Republicans, and there have been rumors over the past several months that HHS might require the premium increases to be applied across all plans, boosting costs for all buyers in the individual market.

Seema Verma, the administrator of the Centers for Medicare & Medicaid Services, told reporters in April that the department was examining the possibility.

Apparently that will not happen, at least not for plan year 2019.

Kaiser Health News is a nonprofit national health policy news service. It is an editorially independent program of the Henry J. Kaiser Family Foundation that is not affiliated with Kaiser Permanente.

Pages

Recommended Reading

Congress passes ‘right to try’ legislation
MDedge Hematology and Oncology
CMS proposes inpatient payment model for CAR T therapies
MDedge Hematology and Oncology
MDedge Daily News: Keeping patients summer safe
MDedge Hematology and Oncology
Peer mentorship, groups help combat burnout in female physicians
MDedge Hematology and Oncology
Geriatric assessments enhance patient care in advanced cancer
MDedge Hematology and Oncology
Metastatic colorectal cancer chemo costs double in Washington vs. British Columbia
MDedge Hematology and Oncology
Looking for lower Medicare drug costs? Ask your pharmacist for the cash price
MDedge Hematology and Oncology
AMA: Opioid prescriptions down since 2013
MDedge Hematology and Oncology
Verma unveils Medicaid scorecard but refuses to judge efforts
MDedge Hematology and Oncology
ASH urges lawmakers to keep opioids accessible
MDedge Hematology and Oncology